Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...

Brisbane Olympic and Paralympic Games plan has been released, and major opportunities and hurdles are on the horizon.

Bloom Credit, an API platform modernizing credit data infrastructure and facilitating real-time reporting and alternative consumer-permissioned data, today announced it is expanding its leadership ...

TransCode (NASDAQ: RNAZ) , the oncology company committed to utilizing RNA therapeutics to more effectively treat cancer, has announced the closing o ...

Johnson & Johnson has been saying for some time that it thinks its combination of Rybrevant and Lazcluze is the best option for patients with EGFR-mutated non-small cell lung cancer (NSCLC) – and now ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 <li /> Up to $7.5 mil ...